77 related articles for article (PubMed ID: 20619429)
1. Murine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5alpha.
Malbec M; Pham QT; Plourde MB; Létourneau-Hogan A; Nepveu-Traversy ME; Berthoux L
Virology; 2010 Sep; 405(2):414-23. PubMed ID: 20619429
[TBL] [Abstract][Full Text] [Related]
2. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
Keckesova Z; Ylinen LM; Towers GJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10780-5. PubMed ID: 15249687
[TBL] [Abstract][Full Text] [Related]
3. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
[TBL] [Abstract][Full Text] [Related]
4. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
[TBL] [Abstract][Full Text] [Related]
6. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
Sokolskaja E; Berthoux L; Luban J
J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
[TBL] [Abstract][Full Text] [Related]
7. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.
Saenz DT; Teo W; Olsen JC; Poeschla EM
J Virol; 2005 Dec; 79(24):15175-88. PubMed ID: 16306589
[TBL] [Abstract][Full Text] [Related]
8. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
[TBL] [Abstract][Full Text] [Related]
9. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW; Nisole S; Lynch C; Stoye JP
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
[TBL] [Abstract][Full Text] [Related]
10. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
11. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
12. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
13. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
14. Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells.
Bérubé J; Bouchard A; Berthoux L
Retrovirology; 2007 Sep; 4():68. PubMed ID: 17892575
[TBL] [Abstract][Full Text] [Related]
15. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of Fv1: effects on retroviral restriction specificities.
Li W; Yap MW; Voss V; Stoye JP
Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
[TBL] [Abstract][Full Text] [Related]
18. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
19. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
Arriagada G; Muntean LN; Goff SP
PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
[TBL] [Abstract][Full Text] [Related]
20. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.
Berthoux L; Towers GJ; Gurer C; Salomoni P; Pandolfi PP; Luban J
J Virol; 2003 Mar; 77(5):3167-80. PubMed ID: 12584341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
